Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Precision Biotech Taiwan Corp

Request full access

Pioneers in cancer immunotherapy

Taipei, TaiwanFounded 2017Biotech & Life Sciences

About Precision Biotech Taiwan Corp

Precision Biotech Taiwan Corp., established on December 6, 2017, is a biotechnology firm specializing in the development and clinical application of immune cell therapies for cancer patients. The company operates within the advanced therapy medicinal products (ATMP) sector, focusing on regenerative medicine and oncology. Its establishment was the culmination of a three-year process of discussion and due diligence between scientific and commercial partners, aiming to integrate capital, technology, and expertise.

The company's business model is centered on the research, development, and provision of cell-based therapeutic products. Its primary clients are hospitals and, by extension, cancer patients. Revenue is generated through the clinical use of its cell preparations, which are supplied to several major hospitals in Taiwan, including Kaohsiung Medical University Chung-Ho Memorial Hospital, Tungs' General Hospital, Kuang Tien General Hospital, and Taipei Chung Shan Hospital, under specific regulatory approvals. The company has received backing from accelerators and incubators, notably the Hong Kong Science and Technology Park.

Precision Biotech's product pipeline features both autologous (using the patient's own cells) and allogeneic (using donor cells) therapies. Key products include PB101, an autologous immune cell preparation, and PB103, an allogeneic Natural Killer (NK) cell preparation. Both are undergoing clinical trials in Taiwan for treating various solid tumors. The company has established a portfolio of core technologies, patents, and know-how in NK cell and gene-editing, creating a platform for genetically engineering NK/NKT cells. This platform supports a research and development pipeline that includes first-in-class universal cell therapy products targeting lung cancer, liver cancer, and other solid and hematologic tumors.

Significant milestones include being recognized as a biotech and new drug company by Taiwan's Ministry of Economic Affairs. In July 2021, its international arm, Precision Biotechnology International Co., Ltd., gained approval to enter the Hong Kong Science Park, with plans to build a PIC/S GMP-compliant cell preparation facility to serve the Greater Bay Area. Concurrently, its allogeneic NK cell product, PB103, has been prepared in Hangzhou, China, for planned Phase I/II multi-center clinical trials.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Rumoured $1B, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jan 2022 $181M $725M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Precision Biotech Taiwan Corp website traffic

Latest recorded traffic for Precision Biotech Taiwan Corp is 2.2K monthly website visits, up 37.5% over the last three months.

Latest monthly visits2.2K 3-month web change+37.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Precision Biotech Taiwan Corp in the Taipei ecosystem

Live from Dealroom

The Precision Biotech Taiwan Corp office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇹🇼 Taiwan · Taipei HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Precision Biotech Taiwan Corp on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Precision Biotech Taiwan Corp’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.